DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Retrovir (Zidovudine) - Adverse Event Reports - All Cases - Drug Exposure During Pregnancy

 



Index of reports > All cases (135) > Cases with Drug Exposure During Pregnancy (37)

Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes all cases where reactions include drug exposure during pregnancy.

 Reports 1 - 25 of 37   Next >>

Adverse event in receiving Retrovir (Zidovudine)

Reported by a individual with unspecified qualification from United States on 2007-10-19

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias

Suspect drug(s):
Viracept
    Administration route: Oral
    Indication: HIV Infection

Videx

Sustiva

Epivir

Norvir

Retrovir

Indinivir Sulfate



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-07-30

Patient: female, weighing 3.9 kg (8.6 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Drug Administration Error, Accidental Overdose

Adverse event resulted in: hospitalization

Suspect drug(s):
Retrovir (Zidovudine)

Other drugs received by patient: Zidovudine



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-24

Patient: male, weighing 3.4 kg (7.4 pounds)

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viracept
    Dosage: daily dose:2500mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Combivir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Kaletra
    Dosage: daily dose:600mg
    Indication: HIV Infection

Retrovir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Viread
    Dosage: daily dose:300mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-29

Patient: male, weighing 2.8 kg (6.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Combivir
    Indication: Antiviral Prophylaxis
    Start date: 2005-02-17
    End date: 2005-04-06

Retrovir
    Dosage: 1.1ml twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2005-04-06
    End date: 2005-05-17

Other drugs received by patient: Retrovir; Kaletra



Adverse event in 28 year old female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient: 28 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection

Retrovir
    Administration route: Oral
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: HIV Infection

Morphine
    Administration route: Oral



Adverse event in receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient:

Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Indication: HIV Infection

Retrovir
    Indication: HIV Infection

Epivir
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Retrovir
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Morphine

Viracept
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: Antiviral Prophylaxis



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-06-18

Patient: female, weighing 2.6 kg (5.7 pounds)

Adverse reactions / side effects: Metabolic Acidosis, Drug Exposure During Pregnancy, Atrioventricular Block Complete, Patent Ductus Arteriosus, Heat Rash, Ventricular Septal Defect, Coarctation of THE Aorta

Suspect drug(s):
Retrovir (Zidovudine)

Other drugs received by patient: Kaletra; Didanosine



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in 28 month old female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29

Patient: 28 month old female

Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Videx
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Retrovir
    Dosage: from the 13th week to the 26th week of gestation.
    Start date: 1997-10-01
    End date: 1998-01-01

Invirase
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Norvir
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: from the 17th week of gestation to the 26th week.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-11-01
    End date: 1998-01-01

Retrovir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-10-01
    End date: 1998-01-01



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-15

Patient: male, weighing 3.4 kg (7.4 pounds)

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viracept
    Dosage: daily dose:2500mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-20

Combivir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Kaletra
    Dosage: daily dose:600mg
    Indication: HIV Infection

Retrovir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Viread
    Dosage: daily dose:300mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-08

Patient: male, weighing 3.4 kg (7.4 pounds)

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viracept
    Dosage: daily dose:2500mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-20

Combivir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Kaletra
    Dosage: daily dose:600mg
    Indication: HIV Infection

Retrovir
    Dosage: daily dose:600mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Viread
    Dosage: daily dose:300mg
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-05-08

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Coarctation of THE Aorta

Suspect drug(s):
Retrovir (Zidovudine)

Other drugs received by patient: Kaletra; Didanosine



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-04

Patient: male, weighing 3.4 kg (7.4 pounds)

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viracept
    Dosage: daily dose:2500mg-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive
    Start date: 2004-01-30
    End date: 2004-06-01

Truvada
    Dosage: daily dose:300mg-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive
    Start date: 2004-06-01
    End date: 2004-07-20

Combivir
    Dosage: daily dose:600mg-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive
    Start date: 2004-01-30
    End date: 2004-06-01

Kaletra
    Dosage: daily dose:600mg-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive

Retrovir
    Dosage: daily dose:600mg-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United Kingdom on 2007-05-03

Patient: male

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension

Suspect drug(s):
Combivir
    Dosage: 600mg per day
    Start date: 2004-01-30
    End date: 2004-06-01

Truvada
    Dosage: 300mg per day
    Start date: 2004-06-01
    End date: 2004-07-20

Viracept
    Dosage: 2500mg per day
    Start date: 2004-01-30
    End date: 2004-06-01

Kaletra
    Dosage: 600mg per day
    Start date: 2004-06-01

Retrovir
    Dosage: 600mg per day
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in 4 year old female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-04-19

Patient: 4 year old female, weighing 21.6 kg (47.5 pounds)

Adverse reactions / side effects: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Tachycardia, Pyrexia, Blood Fibrinogen Increased, Pallor, Acute Lymphocytic Leukaemia, Haemoglobin Decreased, Diarrhoea, C-Reactive Protein Increased, Drug Exposure During Pregnancy, Ecchymosis, Blood Sodium Decreased, Asthenia

Adverse event resulted in: disablity

Suspect drug(s):
Combivir
    Indication: Antiviral Prophylaxis
    Start date: 2002-07-12
    End date: 2002-10-01

Retrovir
    Dosage: .75ml four times per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2002-10-12
    End date: 2002-11-26



Adverse event in receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-17

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Stillbirth, Foetal Malformation

Adverse event resulted in: death

Suspect drug(s):
Retrovir
    Dosage: 500mg per day
    Indication: HIV Infection

Videx
    Dosage: 250mg per day
    Indication: HIV Infection

Viramune
    Indication: HIV Infection



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-11

Patient: male, weighing 2.9 kg (6.4 pounds)

Adverse reactions / side effects: Trisomy 21, Atrial Septal Defect, Drug Exposure During Pregnancy, Patent Ductus Arteriosus

Suspect drug(s):
Combivir
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2006-09-28
    End date: 2006-10-04

Trizivir
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2006-09-21
    End date: 2006-09-21

Retrovir
    Dosage: 476mg per day
    Indication: HIV Infection
    Start date: 2006-10-04
    End date: 2006-10-04



Adverse event in receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03

Patient:

Adverse reactions / side effects: Caesarean Section, Lymphadenopathy, Drug Exposure During Pregnancy, HIV Infection, Human Immunodeficiency Virus Transmission, Failure TO Thrive, Hepatosplenomegaly

Suspect drug(s):
Retrovir
    Indication: Antiviral Prophylaxis

Retrovir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Nevirapine
    Dosage: single dose
    Indication: Antiviral Prophylaxis

Didanosine
    Indication: Antiviral Prophylaxis

Didanosine
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Nevirapine
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis



Adverse event in receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03

Patient:

Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly

Suspect drug(s):
Retrovir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Epivir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Nevirapine
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Quinine Sulfate
    Dosage: transplacentary
    Indication: Plasmodium Falciparum Infection



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-02

Patient: male, weighing 1.4 kg (3.1 pounds)

Adverse reactions / side effects: Congenital Hydronephrosis, Congenital Musculoskeletal Anomaly, Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Patent Ductus Arteriosus, Arachnoid Cyst, Interruption of Aortic Arch, Atrioventricular Septal Defect

Suspect drug(s):
Trizivir
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2006-03-30
    End date: 2006-05-12

Retrovir
    Dosage: 423mg per day
    Indication: HIV Infection
    Start date: 2006-05-10
    End date: 2006-05-10



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-03-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Necrotising Enterocolitis Neonatal

Adverse event resulted in: life threatening event

Suspect drug(s):
Retrovir
    Dosage: 1.6mg twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-19
    End date: 2007-01-26

Retrovir
    Dosage: 2mg twice per day
    Administration route: Oral
    Start date: 2007-01-26
    End date: 2007-02-08

Other drugs received by patient: Antiretroviral Medications



Adverse event in receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from United States on 2007-03-26

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Coarctation of THE Aorta

Suspect drug(s):
Retrovir (Zidovudine)

Other drugs received by patient: Kaletra; Didanosine



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-03-05

Patient: female

Adverse reactions / side effects: Cleft LIP and Palate, Drug Exposure During Pregnancy, Anaemia, Drug Exposure VIA Breast Milk

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2004-02-13

Viracept
    Dosage: 2500mg per day
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Dosage: .46ml four times per day
    Administration route: Oral
    Start date: 2004-06-22
    End date: 2004-08-03

Other drugs received by patient: Lopemin; Ferrum; Utemerin



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-02-27

Patient: female

Adverse reactions / side effects: Dysmorphism, Drug Exposure During Pregnancy

Adverse event resulted in: disablity

Suspect drug(s):
Viracept
    Administration route: Oral
    Indication: HIV Test Positive

Retrovir
    Administration route: Oral
    Indication: HIV Test Positive

Combivir
    Dosage: text:unknown-freq:unknown
    Administration route: Oral
    Indication: HIV Test Positive



Adverse event in receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from South Africa on 2007-02-21

Patient:

Adverse reactions / side effects: Nose Deformity, Drug Exposure During Pregnancy, Premature Baby, Talipes, Limb Malformation

Suspect drug(s):
Epivir
    Dosage: 150mg per day
    Indication: HIV Infection
    Start date: 2005-02-23

Retrovir
    Dosage: 600mg per day
    Indication: HIV Infection
    Start date: 2005-12-29

Zerit
    Dosage: 80mg per day
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Sustiva
    Dosage: 600mg per day
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Viramune
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2005-12-29



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009